- Home
- MOGU vs ATHA Comparison
MOGU vs ATHA Comparison
Compare MOGU & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- ATHA
- Stock Information
- Founded
- MOGU 2011
- ATHA 2011
- Country
- MOGU China
- ATHA United States
- Employees
- MOGU N/A
- ATHA N/A
- Industry
- MOGU Business Services
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- MOGU Consumer Discretionary
- ATHA Health Care
- Exchange
- MOGU Nasdaq
- ATHA Nasdaq
- Market Cap
- MOGU 19.8M
- ATHA 18.2M
- IPO Year
- MOGU 2018
- ATHA 2020
- Fundamental
- Price
- MOGU $2.55
- ATHA $4.72
- Analyst Decision
- MOGU
- ATHA
- Analyst Count
- MOGU 0
- ATHA 0
- Target Price
- MOGU N/A
- ATHA N/A
- AVG Volume (30 Days)
- MOGU 8.8K
- ATHA 25.6K
- Earning Date
- MOGU 11-21-2025
- ATHA 11-06-2025
- Dividend Yield
- MOGU N/A
- ATHA N/A
- EPS Growth
- MOGU N/A
- ATHA N/A
- EPS
- MOGU N/A
- ATHA N/A
- Revenue
- MOGU $19,462,964.00
- ATHA N/A
- Revenue This Year
- MOGU N/A
- ATHA N/A
- Revenue Next Year
- MOGU N/A
- ATHA N/A
- P/E Ratio
- MOGU N/A
- ATHA N/A
- Revenue Growth
- MOGU N/A
- ATHA N/A
- 52 Week Low
- MOGU $1.83
- ATHA $2.20
- 52 Week High
- MOGU $8.10
- ATHA $6.79
- Technical
- Relative Strength Index (RSI)
- MOGU 43.62
- ATHA 61.31
- Support Level
- MOGU $2.54
- ATHA $4.31
- Resistance Level
- MOGU $2.65
- ATHA $4.95
- Average True Range (ATR)
- MOGU 0.14
- ATHA 0.37
- MACD
- MOGU 0.01
- ATHA -0.04
- Stochastic Oscillator
- MOGU 27.27
- ATHA 73.60
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.